John Northcott, SVP & Chief Commercial Officer at NEKTAR THERAPEUTICS (NKTR), sold 4,592 shares at $3.95 ($18K) on 2022-05-16, disclosed to the SEC on 2022-05-17.
Open-market sale of $18k NKTR by SVP & Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| NKTR | SELL | 2021-08-18 | $171K | — | Filing → |
| NKTR | SELL | 2021-05-19 | $223K | — | Filing → |
| NKTR | SELL | 2021-02-18 | $687K | — | Filing → |